本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

DA32 Life Science Tech Acquisition

10.32
0.0000
成交量:- -
成交额:- -
市值:2.65亿
市盈率:153.17
高:10.32
开:10.32
低:10.32
收:10.32
数据加载中...
2022/02/07

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/04

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/04

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/02

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/08/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/08/09

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/08/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/08/09

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/08/09

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/08/09

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/08/09

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/08/09

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/08/05

重要事件披露

8-K - Current report
2021/07/30

重要事件披露

8-K - Current report
2021/07/23

SEC问询函

CORRESP [Cover] - Correspondence
2021/07/23

SEC问询函

CORRESP [Cover] - Correspondence
2021/07/15

SEC问询函

CORRESP [Cover] - Correspondence
2021/07/15

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/07/02

SEC问询函

CORRESP [Cover] - Correspondence
2021/07/02

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933